List of Figures:
Figure 2-1: Global - Protein Therapeutics Market (Billion US$), 2010 & 2011
Figure 2-2: Global - Protein Therapeutics vs Pharmaceutical Market (Billion US$), 2010
Figure 2-3: Global - Protein Therapeutics Market by Segment (%), 2010
Figure 2-4: Global - Forecast for Protein Therapeutics Market (Billion US$), 2012-2014
Figure 2-5: Global - Forecast for Protein Therapeutics Market by Segment (%), 2014
Figure 3-1: Global - Monoclonal Antibodies Market (Billion US$), 2010 & 2011
Figure 3-2: Global - Monoclonal Antibodies Market by Segment (%), 2010
Figure 3-3: Global - Use of Monoclonal Antibodies in Cancer Treatment (Billion US$), 2010 & 2011
Figure 3-4: Global - Use of Monoclonal Antibodies in Rheumatoid Arthritis Treatment (Billion US$), 2010 & 2011
Figure 3-5: Global - Use of Monoclonal Antibodies in Other Chronic Diseases Treatment (Billion US$), 2010 & 2011
Figure 3-6: US - Monoclonal Antibodies Market (Billion US$), 2010 & 2011
Figure 3-7: US - Forecast for Monoclonal Antibodies Market (Billion US$), 2012-2014
Figure 3-8: Europe - Monoclonal Antibodies Market (Billion US$), 2010 & 2011
Figure 3-9: Europe - Forecast for Monoclonal Antibodies Market (Billion US$), 2012-2014
Figure 3-10: Europe - Monoclonal Antibodies Market by Application (%), 2011
Figure 3-11: Japan - Monoclonal Antibodies Market (Billion US$), 2010 & 2011
Figure 3-12: Japan - Forecast for Monoclonal Antibodies Market (Billion US$), 2012-2014
Figure 3-13: Global - Share of Key Players in Monoclonal Antibodies Market (2010)
Figure 3-14: Global - Top Selling Monoclonal Antibodies (Billion US$), 2010
Figure 3-15: Global - Forecast for Monoclonal Antibodies Market (Billion US$), 2012-2014
Figure 3-16: Global - Erythropoietin Market (Billion US$), 2010 & 2011
Figure 3-17: Global - Number of Patients on Dialysis (Million), 2008-2010
Figure 3-18: Global - Breakup of Patients on Dialysis by Region (%), 2010
Figure 3-19: Global - Number of New Cancer Cases (Million), 2008 & 2030
Figure 3-20: Global - Breakup of New Cancer Cases by Region (%), 2008
Figure 3-21: Europe - Erythropoietin Market (Billion US$), 2010-2014
Figure 3-22: Europe - Erythropoietin Biosimilar Market by Country (%), 2010
Figure 3-23: Europe - First Generation Erythropoietin Patent Expiry by Major Country
Figure 3-24: Japan - Erythropoietin Market (Million US$), 2009-2011
Figure 3-25: Global - Forecast for Erythropoietin Market (Billion US$), 2012-2014
Figure 3-26: Europe - Forecast for Share of Oncology and Renal Anemia in Erythropoietin Market (2016)
Figure 3-27: Global - Insulin Market (Billion US$), 2008-2011
Figure 3-28: India - Number of Diabetic Patients (Million), 2010 & 2030
Figure 3-29: India - Insulin Market (Million US$), 2010 & 2011
Figure 3-30: India - Share of Key Players in Insulin Market (2010)
Figure 3-31: China - Insulin Market (Billion RMB), 2009-2011
Figure 3-32: China - Share of Key Players in Insulin Market (2010)
Figure 3-33: US - Insulin Market (Billion US$), 2008-2011
Figure 3-34: US - Share of Key Players in Insulin Market (2010)
Figure 3-35: Russia - Insulin Market (Million US$), 2009-2011
Figure 3-36: Russia - Share of Key Players in Insulin Market (H1 2009)
Figure 3-37: Japan - Insulin Market (Million US$), 2008-2011
Figure 3-38: Japan - Share of Key Players in Insulin Market (2009)
Figure 3-39: Germany - Share of Insulin in Genetically Manufactured Pharmaceuticals Market (2007)
Figure 3-40: Brazil - Insulin Market (Million US$), 2008-2011
Figure 3-41: Brazil - Share of Key Players in Insulin Market (2010)
Figure 3-42: Global - Share of Key Players in Insulin Market (2010)
Figure 3-43: Global - Share of Brands in Insulin Market (2010)
Figure 3-44: Global - Number of Diabetic Patients (Million), 2010 & 2030
Figure 3-45: Global - Forecast for Insulin Market (Billion US$), 2012-2014
Figure 3-46: Global - Interferon Market (Billion US$), 2008-2011
Figure 3-47: Global - Share of Alpha and Beta in Interferon Market (2010)
Figure 3-48: Global - Interferon Alpha Market (Billion US$), 2008-2010
Figure 3-49: Global - Hepatitis B Treatment Market (Billion US$), 2010-2014
Figure 3-50: Global - Hepatitis C Treatment Market (Billion US$), 2010-2014
Figure 3-51: Global - Interferon Beta Market (Billion US$), 2008-2010
Figure 3-52: Global - Multiple Sclerosis Treatment Market (Billion US$), 2008-2010
Figure 3-53: US - Interferon Market (Billion US$), 2006 & 2010
Figure 3-54: Europe - Interferon Market (Million US$)
Figure 3-55: Japan - Interferon Market (Million US$), 2007-2010
Figure 3-56: Global - Forecast for Interferon Market (Billion US$), 2012-2014
Figure 3-57: Global - Human Growth Hormone Market (Billion US$), 2008-2011
Figure 3-58: US, Europe & Japan - Number of Patients with Pediatric Growth Hormone Deficiency (‘000)
Figure 3-59: Global - Share of Growth Hormones in Treatment of Pediatric Short Stature
Figure 3-60: Global - Adult Growth Hormone Deficiency Market (Million US$)
Figure 3-61: Global - Human Growth Hormone Market by Region (%), 2009
Figure 3-62: US & Europe - Human Growth Hormone Market (Million US$), 2009
Figure 3-63: Japan - Human Growth Hormone Market (Million US$), 2007-2009
Figure 3-64: Global - Share of Key Players in Human Growth Hormone Market (2010)
Figure 3-65: Global - Forecast for Human Growth Hormone Market (Billion US$), 2012-2014
Figure 3-66: Global - Blood Clotting Factor Market (Billion US$), 2008-2011
Figure 3-67: Global - Share of Blood Clotting Factor Market by Segment (2010)
Figure 3-68: Global - Share of Key Players in Blood Clotting Factor Market (2010)
Figure 3-69: Global - Forecast for Blood Clotting Factor Market (Billion US$), 2012-2014
Figure 3-70: Global - Follicle Stimulating Hormone Market (Billion US$), 2008-2011
Figure 3-71: Global - Forecast for Follicle Stimulating Hormone Market (Billion US$), 2012-2014
Figure 3-72: Global - Granulocyte Colony Stimulating Factor Market (Billion US$), 2008-2011
Figure 3-73: US - Share in Global Granulocyte Colony Stimulating Factor Market
Figure 3-74: Global - Forecast for Granulocyte Colony Stimulating Factor Market (Billion US$), 2012-2014
Figure 4-1: Global - Nanotechnology-enabled Drug Delivery Market (Billion US$), 2007 & 2012
List of Tables:
Table 3-1: Global - Key Players and Drugs in Erythropoietin Alfa Market (Million US$), 2010
Table 3-2: Global - Key Players and Drugs in Erythropoietin Beta Market (Million US$), 2010
Table 3-3: Global - Key Players and Drugs in Darbepoetin Market (Million US$), 2010
Table 3-4: China - Diabetic Patients in Age Group 20-79 Years (‘000), 2010 & 2030
Table 3-5: US - Diabetic Patients in Age Group 20-79 Years ('000), 2010 & 2030
Table 3-6: Russia - Diabetic Patients in Age Group 20-79 Years ('000), 2010 & 2030
Table 3-7: Japan - Diabetic Patients in Age Group 20-79 Years ('000), 2010 & 2030
Table 3-8: Germany - Diabetic Patients in Age Group 20-79 Years ('000), 2010 & 2030
Table 3-9: Brazil - Diabetic Patients in Age Group 20-79 Years ('000), 2010 & 2030
Table 3-10: Global - Key Players and Drugs in Interferon Alpha Market (Million US$), 2010
Table 3-11: Global - Key Players and Drugs in Interferon Beta Market (Million US$), 2010
Table 3-12: Global - Key Players and Drugs in Human Growth Hormone Market (Million US$), 2010
Table 3-13: Global - Key Players and Drugs in Blood Clotting Factor Market (Million US$), 2010
Table 3-14: Global - Key Players and Drugs in Follicle Stimulating Hormone Market (Million US$), 2010
Table 3-15: Global - Key Players and Drugs in Granulocyte Colony Stimulating Factor Market (Million US$), 2010
